Join to view full profile
329 Maine StSte E101Brunswick, ME 04011
Phone+1 207-373-2266
Fax+1 207-910-4413
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Gullo, MD is an oncologist in Brunswick, Maine. He is currently licensed to practice medicine in Maine, North Carolina, and Massachusetts.
Education & Training
MedStart Georgetown University HospitalFellowship, Medical Oncology, 1979
SUNY Upstate Medical UniversityResidency, Internal Medicine, 1972 - 1975
SUNY Upstate Medical UniversityInternship, Transitional Year, 1971 - 1972
SUNY Upstate Medical UniversityClass of 1972
Certifications & Licensure
ME State Medical License 2017 - 2027
MA State Medical License 2014 - 2023
NC State Medical License 2022 - 2022
NY State Medical License 1979 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
Publications & Presentations
PubMed
- 29 citationsRandomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer.Elizabeth Poplin, Patricia LoRusso, Jacob J. Lokich, John J. Gullo, Philip D. Leming
Cancer Chemotherapy and Pharmacology. 1994-01-01 - 1 citationsDichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer. A MAOP study.Galen L. Wampler, James D. Ahlgren, Jacob J. Lokich, John J. Gullo, James A. Phillips
American Journal of Clinical Oncology. 1991-10-01 - 19 citationsProtracted infusion of 5-FU with weekly low-dose cisplatin as second-line therapy in patients with metastatic colorectal cancer who have failed 5-FU monotherapy.James D. Ahlgren, Orrawin Trocki, John J. Gullo, Richard M. Goldberg, W. Angus Muir
Cancer Investigation. 1991-01-01










